Assessing Hospital Resource Utilization with Application to Imaging for Patients Diagnosed with Prostate Cancer

Assessing Hospital Resource Utilization with Application to Imaging for Patients Diagnosed with Prostate Cancer

Resource utilization measures are typically modeled by relying on clinical characteristics. However, in some settings, those clinical markers are not available, and hospitals are unable to explore potential inefficiencies or resource misutilization. We propose a novel approach to exploring misutiliz...

Full description

Bibliographic Details
Main Authors:	Yazmine Lunn, Rudra Patel, Timothy S. Sokphat, Laura Bourn, Khalil Fields, Anna Fitzgerald, Vandana Sundaresan, Greeshma Thomas, Michael Korvink, Laura H. Gunn
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Healthcare
Subjects:	resource utilization misutilization medical imaging prostate cancer risk adjustment
Online Access:	https://www.mdpi.com/2227-9032/10/2/248

Similar Items

Establishment and implementation of an improvement plan using Lean Six Sigma methodology to minimize variation in ordering laboratory tests
by: Salwa H Gomaa, et al.
Published: (2022-01-01)

Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec
by: Jason Hu, et al.
Published: (2022-11-01)

HOW PROSTATE TUBERCULOSIS IS DIAGNOSED
by: S. Yu. Shevchenko, et al.
Published: (2017-07-01)

Estimation of Utility Weights for Prostate-related Health States in Korea
by: Seon-Ha Kim, et al.
Published: (2022-05-01)

Healthcare utilization and costs in patients with benign prostatic hyperplasia: a population-based study
by: Shiu-Dong Chung, et al.
Published: (2016-01-01)

Correlation between prostate volume and prostate-specific antigen in patients diagnosed with benign prostatic hyperplasia
by: Udoh EA, et al.
Published: (2020-12-01)

The Management of Patients Diagnosed with Incidental Prostate Cancer: Narrative Review
by: Abedi AR, et al.
Published: (2020-03-01)

Prostate Cancer Screening Using Prostate-Specific Antigen Tests in a High-Risk Population in China: A Cost-Utility Analysis
by: Xiaojian Qin, PhD, et al.
Published: (2021-01-01)

BIOMARKERS FOR DIAGNOSING OF PROSTATE CANCER: THE PRESENT AND THE FUTURE
by: L. M. Rapoport, et al.
Published: (2018-05-01)

New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3
by: Chen Huang, et al.
Published: (2022-07-01)

Cost–Utility Analysis of Radiation Treatment Modalities for Intermediate-Risk Prostate Cancer
by: Najlaa Alyamani, et al.
Published: (2021-06-01)

Repeat prostate biopsies following diagnoses of prostate intraepithelial neoplasia and atypical small gland proliferation
by: Katia R. Leite, et al.
Published: (2005-04-01)

The utility of digital rectal examination in estimating prostate volume in a rural hospital setting
by: E I Udeh, et al.
Published: (2015-01-01)

Association of prostate volume with incidence and aggressiveness of prostate cancer
by: Al-Khalil S, et al.
Published: (2016-10-01)

The Molecular Basis and Clinical Consequences of Chronic Inflammation in Prostatic Diseases: Prostatitis, Benign Prostatic Hyperplasia, and Prostate Cancer
by: Saheed Oluwasina Oseni, et al.
Published: (2023-06-01)

Degarelix vs. leuprorelin for the treatment of prostate cancer in China: A cost-utility analysis
by: Jianzhou Yan, et al.
Published: (2022-07-01)

Malakoplakia of the prostate diagnosed by elevated PSA level and transrectal prostate biopsy
by: Sacit Nuri Görgel, et al.
Published: (2011-04-01)

New model of PIRADS and adjusted prostatespecific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study
by: Chen Huang, et al.
Published: (2023-01-01)

Evaluation of serum prostatic-specific antigen levels in diabetic and non-diabetic men diagnosed with benign prostatic hyperplasia
by: Udoh EA, et al.
Published: (2022-01-01)

Histopathological variant types diagnosed in prostate surgery
by: Semih Aktaş, et al.
Published: (2020-12-01)

Cost-efficacy analysis of hormonal treatments for advanced prostate cancer
by: Sergio Iannazzo, et al.
Published: (2008-09-01)

Cost Analysis of Screening for, Diagnosing, and Staging Prostate Cancer Based on a Systematic Review of Published Studies
by: Donatus U. Ekwueme, PhD, et al.
Published: (2007-10-01)

A Trial-Based Cost-Utility Analysis of Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer
by: Elise De Bleser, et al.
Published: (2020-01-01)

Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination
by: Ari Miotto Jr, et al.
Published: (2004-04-01)

Global Burden of Prostate Cancer and Association with Socioeconomic Status, 1990–2019: A Systematic Analysis from the Global Burden of Disease Study
by: Weiyu Zhang, et al.
Published: (2023-05-01)

Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
by: Govinda Nanjaiah Laxmana Raju, et al.
Published: (2023-06-01)

Burden of Prostate Cancer in China, 1990–2019: Findings From the 2019 Global Burden of Disease Study
by: Fuquan Wang, et al.
Published: (2022-05-01)

Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer
by: Watanabe K, et al.
Published: (2021-08-01)

Evaluation of the resistive index of prostatic blood flow in benign prostatic hyperplasia
by: Osama Abdelwahab, et al.
Published: (2012-04-01)

The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer
by: Wietske I. Luining, et al.
Published: (2024-01-01)

Diagnostic accuracy of prostate-specific antigen below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting: A systematic review and meta-analysis
by: Yan Jin, et al.
Published: (2022-05-01)

Nonspecific granulomatous prostatitis with prostatic adenocarcinoma
by: Murugan Paari, et al.
Published: (2010-01-01)

Performance analysis of turbine extraction superheat utilization schemes of built power plant
by: Lei Zhang, et al.
Published: (2020-11-01)

Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
by: Lin Bai, et al.
Published: (2020-06-01)

Bone scintigraphy in staging of newly diagnosed prostate cancer in regard of different risk groups
by: Sabina Sevcenco, et al.
Published: (2019-06-01)

An improbable trifecta: Occurrence of xanthogranulomatous prostatitis, prostate cancer, and prostatic abscess in a single patient
by: Jonathan Demeter, et al.
Published: (2021-03-01)

When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study
by: Yiwei Lin, et al.
Published: (2017-06-01)

Development and validation of a predictive model for diagnosing prostate cancer after transperineal prostate biopsy
by: Wenming Ren, et al.
Published: (2022-12-01)

EQUINOXE study: Impact of relational cohesion and sexuality on the quality of life of patients treated with gonadotropin‐releasing hormone agonist for prostate cancer
by: Stéphane Droupy, et al.
Published: (2022-01-01)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
by: Sung Han Kim, et al.
Published: (2021-04-01)